Prafull Ghatage

Prafull Ghatage

UNVERIFIED PROFILE

Are you Prafull Ghatage?   Register this Author

Register author
Prafull Ghatage

Prafull Ghatage

Publications by authors named "Prafull Ghatage"

Are you Prafull Ghatage?   Register this Author

49Publications

1274Reads

11Profile Views

The Impact of Gynaecological Tumour Board Rounds on Patient Care.

J Obstet Gynaecol Can 2019 Feb 2;41(2):180-184.e1. Epub 2018 Nov 2.

Department of Oncology, University of Calgary, Calgary, AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2018.05.026DOI Listing
February 2019

Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

Authors:
Peter F Rambau Robert A Vierkant Maria P Intermaggio Linda E Kelemen Marc T Goodman Esther Herpel Paul D Pharoah Stefan Kommoss Mercedes Jimenez-Linan Beth Y Karlan Aleksandra Gentry-Maharaj Usha Menon Susanna Hernando Polo Francisco J Candido Dos Reis Jennifer Anne Doherty Simon A Gayther Raghwa Sharma Melissa C Larson Paul R Harnett Emma Hatfield Jurandyr M de Andrade Gregg S Nelson Helen Steed Joellen M Schildkraut Micheal E Carney Estrid Høgdall Alice S Whittemore Martin Widschwendter Catherine J Kennedy Frances Wang Qin Wang Chen Wang Sebastian M Armasu Frances Daley Penny Coulson Micheal E Jones Micheal S Anglesio Christine Chow Anna de Fazio Montserrat García-Closas Sara Y Brucker Cezary Cybulski Holly R Harris Andreas D Hartkopf Tomasz Huzarski Allan Jensen Jan Lubiński Oleg Oszurek Javier Benitez Fady Mina Annette Staebler Florin Andrei Taran Jana Pasternak Aline Talhouk Mary Anne Rossing Joy Hendley Robert P Edwards Sian Fereday Francesmary Modugno Roberta B Ness Weiva Sieh Mona A El-Bahrawy Stacey J Winham Jenny Lester Susanne K Kjaer Jacek Gronwald Peter Sinn Peter A Fasching Jenny Chang-Claude Kirsten B Moysich David D Bowtell Brenda Y Hernandez Hugh Luk Sabine Behrens Mitul Shah Audrey Jung Prafull Ghatage Jennifer Alsop Kathryn Alsop Jesús García-Donas Pamela J Thompson Anthony J Swerdlow Chloe Karpinskyj Alicia Cazorla-Jiménez María J García Susha Deen Lynne R Wilkens José Palacios Andrew Berchuck Jennifer M Koziak James D Brenton Linda S Cook Ellen L Goode David G Huntsman Susan J Ramus Martin Köbel

J Pathol Clin Res 2018 10 21;4(4):250-261. Epub 2018 Sep 21.

Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174617PMC
October 2018

Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study.

Int J Gynecol Cancer 2018 06;28(5):925-931

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Beaumont Medical Center, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001244DOI Listing
June 2018

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

Mayo Clin Proc 2018 03;93(3):307-320

Department of Health Sciences Research, Mayo Clinic, Rochester, MN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2017.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870793PMC
March 2018

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Authors:
Ellen L Goode Matthew S Block Kimberly R Kalli Robert A Vierkant Wenqian Chen Zachary C Fogarty Aleksandra Gentry-Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L Bouligny Allan Jensen Ana Osorio Andreas Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M Magliocco Arndt Hartmann Audrey Y Jung Bo Gao Brenda Y Hernandez Brooke L Fridley Bryan M McCauley Catherine J Kennedy Chen Wang Chloe Karpinskyj Christiani B de Sousa Daniel G Tiezzi David L Wachter Esther Herpel Florin Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donas Jill Nation Jillian Hung José Palacios Joseph H Rothstein Joseph L Kelley Jurandyr M de Andrade Luis Robles-Díaz Maria P Intermaggio Martin Widschwendter Matthias W Beckmann Matthias Ruebner Mercedes Jimenez-Linan Naveena Singh Oleg Oszurek Paul R Harnett Peter F Rambau Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P Edwards Roberta B Ness Sandra Orsulic Sara Y Brucker Sharon E Johnatty Teri A Longacre Eilber Ursula Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S Whittemore deFazio Anna Annette Staebler Beth Y Karlan Blake Gilks David D Bowtell Estrid Høgdall Francisco J Candido dos Reis Helen Steed Ian G Campbell Jacek Gronwald Javier Benítez Jennifer M Koziak Jenny Chang-Claude Kirsten B Moysich Linda E Kelemen Linda S Cook Marc T Goodman María José García Peter A Fasching Stefan Kommoss Suha Deen Susanne K Kjaer Usha Menon James D Brenton Paul DP Pharoah Georgia Chenevix-Trench David G Huntsman Stacey J Winham Martin Köbel Susan J Ramus

JAMA Oncol 2017 12;3(12):e173290

School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744673PMC
December 2017

Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study.

Gynecol Oncol 2017 11 8;147(2):257-261. Epub 2017 Aug 8.

Division of Gynecologic Oncology, Beaumont Health, MI, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.08.006DOI Listing
November 2017

A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy.

Int J Gynecol Cancer 2017 05;27(4):668-674

*Division of Gynecologic Oncology, Princess Margaret Cancer Center; †Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON; ‡Division of Gynecologic Oncology, Tom Baker Cancer Centre; §Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB; ∥Women's College Research Institute, Women's College Hospital; ¶Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; and #Beaumont Medical Group, Gynecologic Oncology, Royal Oak, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000946DOI Listing
May 2017

Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.

Int J Mol Sci 2017 Feb 27;18(3). Epub 2017 Feb 27.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2N 2T9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18030515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372531PMC
February 2017

Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.

Histopathology 2016 Aug 26;69(2):288-97. Epub 2016 Feb 26.

Department of Pathology and Laboratory Medicine, Calgary Laboratory Services/Alberta Health Services and University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12934DOI Listing
August 2016

Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer.

Expert Opin Pharmacother 2016 21;17(6):853-60. Epub 2016 Mar 21.

a Division of Gynecologic Oncology , Tom Baker Cancer Centre , Calgary , AB , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1161027DOI Listing
August 2016

Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer.

Gynecol Oncol 2014 Nov 28;135(2):184-9. Epub 2014 Aug 28.

Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto ON Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258140107
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2014.06.033DOI Listing
November 2014

PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.

Gynecol Oncol 2014 Jan 19;132(1):188-93. Epub 2013 Nov 19.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada; Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.015DOI Listing
January 2014

A rare case of NUT midline carcinoma.

Gynecol Oncol Case Rep 2012 8;3:1-3. Epub 2012 Oct 8.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gynor.2012.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862205PMC
December 2013

The effects of anemia and blood transfusion on patients with stage III-IV ovarian cancer.

Int J Gynecol Cancer 2013 Nov;23(9):1569-76

*Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Winnipeg Health Sciences Centre & CancerCare Manitoba; and †Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba; and ‡Tom Baker Cancer Centre & Foothills Medical Centre and Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e3182a57ff6DOI Listing
November 2013

Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology.

Diagn Cytopathol 2013 Sep 22;41(9):767-75. Epub 2013 Jan 22.

Department of Anatomic Pathology, Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22944DOI Listing
September 2013

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors.

Mod Pathol 2013 Sep 5;26(9):1255-63. Epub 2013 Apr 5.

Department of Obstetrics and Gynecology, Division of Gynecological Oncology, Winnipeg Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.55DOI Listing
September 2013

PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy.

Gynecol Oncol 2013 Mar 22;128(3):409-14. Epub 2012 Dec 22.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.12.019DOI Listing
March 2013

Quantification of ER/PR expression in ovarian low-grade serous carcinoma.

Gynecol Oncol 2013 Feb 24;128(2):371-6. Epub 2012 Oct 24.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.10.013DOI Listing
February 2013

Dose-dense paclitaxel with carboplatin for advanced ovarian cancer: a feasible treatment alternative.

J Obstet Gynaecol Can 2013 Jan;35(1):61-7

Department of Gynecologic Oncology, Tom Baker Cancer Centre, Calgary AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(15)31050-1DOI Listing
January 2013

Is there a role for tirapazamine in the treatment of cervical cancer?

Expert Opin Drug Metab Toxicol 2012 Dec 4;8(12):1589-97. Epub 2012 Oct 4.

Tom Baker Cancer Centre, Department of Gynecologic Oncology, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2012.730518DOI Listing
December 2012

Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature.

Int J Gynecol Cancer 2012 Jul;22(6):1006-12

Winnipeg Health Sciences Centre & Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31825b7de8DOI Listing
July 2012

Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study.

J Obstet Gynaecol Can 2012 Jul;34(7):664-72

Winnipeg Health Science Centre, CancerCare Manitoba, Gynecologic Oncology, Winnipeg MB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)35320-8DOI Listing
July 2012

Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery.

J Obstet Gynaecol Can 2012 Jun;34(6):558-566

Tom Baker Cancer Centre and Foothills Medical Centre, University of Calgary, Calgary AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(16)35272-0DOI Listing
June 2012

Vacuum assisted wound closures in gynaecologic surgery.

J Obstet Gynaecol Can 2011 Oct;33(10):1031-1037

Tom Baker Cancer Centre and Foothills Medical Centre, University of Calgary, Calgary AB.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S17012163163505
Publisher Site
http://dx.doi.org/10.1016/S1701-2163(16)35052-6DOI Listing
October 2011

Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.

Arch Gynecol Obstet 2011 Sep 21;284(3):731-5. Epub 2010 Oct 21.

Department of Gynecology Oncology, Tom Baker Cancer Centre, 3330 Hospital Drive NW, Calgary, AB, T2N 4N1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-010-1713-9DOI Listing
September 2011

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

J Med Virol 2011 Jun;83(6):1034-41

Department of Microbiology and Infectiology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.22081DOI Listing
June 2011

AMG 386: profile of a novel angiopoietin antagonist in patients with ovarian cancer.

Expert Opin Investig Drugs 2011 Feb 6;20(2):297-304. Epub 2011 Jan 6.

Amgen Canada, Inc., Regional Medical Liaison - Oncology, 6775 Financial Drive, Mississauga, Ontario L5N 0A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.549125DOI Listing
February 2011

Malignant chest wall endometriosis: a case report and literature review.

J Obstet Gynaecol Can 2009 Jun;31(6):538-541

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary AB; Tom Baker Cancer Centre, Calgary AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1701-2163(16)34217-7DOI Listing
June 2009

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.

J Clin Oncol 2008 Sep 30;26(26):4319-25. Epub 2008 Jun 30.

Princess Margaret Hospital, University Health Network, Bras Family Drug Development Program, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.8808DOI Listing
September 2008

Primary carcinoma of the rectovaginal septum diagnosed as uterine prolapse.

J Obstet Gynaecol Can 2005 Nov;27(11):1027-30

Department of Obstetrics and Gynecology, Foothills Medical Centre, Calgary, AB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1701-2163(16)30502-3DOI Listing
November 2005

Granulosa cell tumour of the broad ligament.

Pathology 2003 Jun;35(3):265-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0031302031000151037DOI Listing
June 2003